SCHEMBL5160832

SCHEMBL5160832

C=CC[C@H](C(=O)N1C(=O)OCC1Cc1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.46
PPARA Q07869 2/20 0.42
IL6ST P40189 1/20 0.40
NAAA Q02083 1/20 0.39
IDH1 O75874 8/20 0.39
AGTR2 P50052 2/20 0.39
CHRM1 P11229 1/20 0.36
FAAH O00519 1/20 0.36
HDAC1 Q13547 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5160821 1.00 CYP2C19 (0.46) CYP2C19PPARAIL6STNAAAIDH1
SCHEMBL5160825 1.00 CYP2C19 (0.46) CYP2C19PPARAIL6STNAAAIDH1
SCHEMBL6421893 1.00 CYP2C19 (0.46) CYP2C19PPARAIL6STNAAAIDH1
SCHEMBL7350496 1.00 CYP2C19 (0.46) CYP2C19PPARAIL6STNAAAIDH1
SCHEMBL7350489 1.00 CYP2C19 (0.46) CYP2C19PPARAIL6STNAAAIDH1
SCHEMBL6422007 0.93 PPARA (0.40) CYP2C19PPARAIL6STNAAAIDH1
SCHEMBL6422013 0.93 PPARA (0.40) CYP2C19PPARAIL6STNAAAIDH1
SCHEMBL6421904 0.89 PPARA (0.41) CYP2C19PPARAIL6STNAAAIDH1
SCHEMBL6581468 0.89 PPARA (0.41) CYP2C19PPARAIL6STNAAAIDH1
SCHEMBL6421902 0.89 PPARA (0.41) CYP2C19PPARAIL6STNAAAIDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1126836-B1 BENZAMIDE POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2007-02-14 EP disclosed
EP-1126836-A4 BENZAMIDE POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2002-09-04 EP disclosed
EP-1126836-A1 BENZAMIDE POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2001-08-29 EP disclosed
US-6194458-B1 1-(2-METHOXYPHENYL)-1-OXO-2-AZA-(S)-4-I-BUTYL-4-PHENYLBUTANE, FOR EXAMPLE; TREATING VARIOUS CONDITIONS INCLUDING TRANSPLANTATION REJECTION OF ORGANS OR TISSUES IN A PATIENT; IMMUNOSUPPRESSANT COMPOSITIONS MERCK & CO., INC. 2001-02-27 US disclosed
WO-2000025774-A1 BENZAMIDE POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2000-05-11 WO disclosed